Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Eris Lifesciences Limited
Eris Lifesciences Limited has been a registered company since 2007, making it 19 years old. Its CIN is L24232GJ2007PLC049867, with registration number 49867. The organization is recorded as company limited by shares under Indian company law. Authorized capital of the company is recorded at ₹30.00 crore. It has a paid-up capital totaling ₹13.61 crore.
Its principal business sector is manufacture of other chemical products. The company has been registered in the city of Ahmedabad. Its official registered office is situated at Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380054. It is an active company at present. The entity’s PAN (Permanent Account Number) stands as AABCE7067M. As per official records, the company’s LEI is 33580023SPXBP9PCKQ56. The company’s official contact email is complianceofficer@erislifesciences.com. The senior leadership includes Sachin Shah (CFO).
Company Overview
- CIN
- Date of Incorporation
- 24/01/2007
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2023
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹30,00,00,000.00
- Paid up Capital
- ₹13,61,05,792.00
- Activity
- Manufacture of other chemical products
- complianceofficer@erislifesciences.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AABCE7067M1Z6 | Active |
| Assam | 18AABCE7067M5Z2 | Active |
| 18AABCE7067M4Z3 | Active | |
| 18AABCE7067M6Z1 | Inactive | |
| 18AABCE7067M1Z6 | Inactive | |
| 18AABCE7067M3Z4 | Inactive | |
| 18AABCE7067M2Z5 | Inactive | |
| Bihar | 10AABCE7067M1ZM | Active |
| Chhattisgarh | 22AABCE7067M1ZH | Active |
| Delhi | 07AABCE7067M1Z9 | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE406M08029 | ERIS LIFESCIENCES LIMITED STRPP II 8.73 NCD 07JU27 FVRS1LAC | 8.73% | 07/06/2027 | ERIS LIFESCIENC/8.73 DEB SNR | DBFUFN |
| INE406M08011 | ERIS LIFESCIENCES LIMITED STRPP I 8.73 NCD 07DC26 FVRS1LAC | 8.73% | 07/12/2026 | ERIS LIFESCIENC/8.73 DEB SNR | DBFUFN |
| INE406M01024 | ERIS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- | - | 12/10/2026 | ERIS LIFESCIENC/SH VTG | ESVUFN |
| IN8406M01015 | ERIS LIFESCIENCES LIMITED EQ NEW FV RE. 1/-TRADING APPROVAL AWAITED | - | 12/10/2026 | ERIS LIFESCIENC/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net PPE | ₹98,134.00L | ₹75,587.00L | ₹56,882.00L | ₹38,916.80L |
| Net Debt | ₹2,25,503.00L | ₹2,22,202.00L | ₹2,64,114.00L | ₹77,407.00L |
| Goodwill | ₹91,197.00L | ₹91,197.00L | ₹86,717.00L | ₹33,184.90L |
| Gross PPE | ₹1,19,912.00L | ₹97,718.00L | ₹71,386.00L | ₹48,254.10L |
| Inventory | ₹43,682.00L | ₹33,483.00L | ₹18,903.00L | ₹13,143.50L |
| Total Debt | ₹2,35,862.00L | ₹2,47,792.00L | ₹2,78,128.00L | ₹87,671.10L |
| Common Stock | ₹1,385.00L | ₹1,362.00L | ₹1,360.00L | ₹1,359.90L |
| Current Debt | ₹1,35,385.00L | ₹68,415.00L | ₹2,08,077.00L | ₹18,556.90L |
| Share Issued | ₹1,385.43L | ₹1,361.63L | ₹1,360.28L | ₹1,359.92L |
| Total Assets | ₹7,36,551.00L | ₹7,03,641.00L | ₹7,04,046.00L | ₹3,66,732.80L |
| Capital Stock | ₹1,385.00L | ₹1,362.00L | ₹1,360.00L | ₹1,359.90L |
| Long Term Debt | ₹95,583.00L | ₹1,73,751.00L | ₹65,451.00L | ₹64,444.70L |
| Current Assets | ₹1,53,985.00L | ₹1,22,623.00L | ₹2,30,204.00L | ₹76,472.20L |
| Prepaid Assets | ₹13,405.00L | ₹8,988.00L | ₹14,342.00L | ₹8,643.20L |
| Working Capital | -₹53,725.00L | -₹15,840.00L | -₹23,003.00L | ₹32,148.90L |
| Invested Capital | ₹6,21,236.00L | ₹5,27,602.00L | ₹5,32,146.00L | ₹3,02,600.40L |
| Other Properties | ₹22,427.00L | ₹23,614.00L | ₹20,815.00L | ₹15,394.90L |
| Retained Earnings | ₹3,40,701.00L | ₹2,79,276.00L | ₹2,54,094.00L | ₹2,15,593.00L |
| Common Stock Equity | ₹3,90,268.00L | ₹2,85,436.00L | ₹2,58,618.00L | ₹2,19,598.80L |
| Net Tangible Assets | -₹57,651.00L | -₹1,79,032.00L | -₹1,19,434.00L | -₹1,645.70L |
| Tangible Book Value | -₹57,651.00L | -₹1,79,032.00L | -₹1,19,434.00L | -₹1,645.70L |
| Current Liabilities | ₹2,07,710.00L | ₹1,38,463.00L | ₹2,53,207.00L | ₹44,323.30L |
| Long Term Provisions | ₹8,678.00L | ₹6,898.00L | ₹5,272.00L | ₹4,411.90L |
| Stockholders Equity | ₹3,90,268.00L | ₹2,85,436.00L | ₹2,58,618.00L | ₹2,19,598.80L |
| Other Equity Interest | ₹1,426.00L | ₹1,009.00L | ₹502.00L | ₹280.20L |
| Total Capitalization | ₹4,85,851.00L | ₹4,59,187.00L | ₹3,24,069.00L | ₹2,84,043.50L |
| Hedging Assets Current | ₹40.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹1,385.43L | ₹1,361.63L | ₹1,360.28L | ₹1,359.92L |
| Other Intangible Assets | ₹3,56,722.00L | ₹3,73,271.00L | ₹2,91,335.00L | ₹1,88,059.60L |
| Other Non Current Assets | ₹17.00L | ₹18.00L | ₹17.50L | ₹0.10L |
| Total Non Current Assets | ₹5,82,566.00L | ₹5,81,018.00L | ₹4,73,842.00L | ₹2,90,260.60L |
| Cash And Cash Equivalents | ₹5,465.00L | ₹19,964.00L | ₹9,414.00L | ₹5,594.60L |
| Construction In Progress | ₹27,297.00L | ₹9,381.00L | ₹2,957.00L | ₹3,316.80L |
| Accumulated Depreciation | -₹21,778.00L | -₹22,131.00L | -₹14,504.00L | -₹9,337.30L |
| Additional Paid In Capital | ₹46,096.00L | ₹2,951.00L | ₹1,824.00L | ₹1,527.50L |
| Other Short Term Investments | ₹78.00L | ₹573.00L | ₹1,24,460.00L | ₹3,000.70L |
| Other Non Current Liabilities | -₹1.00L | ₹458.00L | ₹138.40L | ₹1,132.20L |
| Machinery Furniture Equipment | ₹31,117.00L | ₹27,172.00L | ₹21,876.00L | ₹13,924.70L |
| Goodwill And Other Intangible Assets | ₹4,47,919.00L | ₹4,64,468.00L | ₹3,78,052.00L | ₹2,21,244.50L |
| Total Equity Gross Minority Interest | ₹3,89,567.00L | ₹3,27,176.00L | ₹3,22,209.00L | ₹2,22,067.70L |
| Total Liabilities Net Minority Interest | ₹3,46,984.00L | ₹3,76,465.00L | ₹3,81,837.00L | ₹1,44,665.10L |
| Current Debt And Capital Lease Obligation | ₹1,36,260.00L | ₹69,620.00L | ₹2,08,975.00L | ₹19,329.00L |
| Long Term Debt And Capital Lease Obligation | ₹99,602.00L | ₹1,78,172.00L | ₹69,153.00L | ₹68,342.10L |
| Cash Cash Equivalents And Short Term Investments | ₹5,543.00L | ₹20,537.00L | ₹1,33,874.00L | ₹8,595.30L |
| Total Non Current Liabilities Net Minority Interest | ₹1,39,274.00L | ₹2,38,002.00L | ₹1,28,630.00L | ₹1,00,341.80L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net Income | ₹61,952.00L | ₹35,184.00L | ₹39,198.30L | ₹38,215.80L |
| Free Cash Flow | ₹24,113.00L | ₹91,001.00L | ₹35,685.00L | -₹54,968.30L |
| Changes In Cash | -₹14,500.00L | ₹10,372.00L | ₹1,127.00L | -₹233.80L |
| End Cash Position | ₹5,474.00L | ₹19,974.00L | ₹9,425.00L | ₹5,602.20L |
| Financing Cash Flow | -₹31,353.00L | -₹88,132.00L | ₹1,37,978.00L | ₹68,802.50L |
| Investing Cash Flow | -₹36,946.00L | -₹7,997.00L | -₹1,85,452.00L | -₹98,210.10L |
| Operating Cash Flow | ₹53,799.00L | ₹1,06,501.00L | ₹48,601.00L | ₹29,173.80L |
| Capital Expenditure | -₹29,686.00L | -₹15,500.00L | -₹12,916.00L | -₹84,142.10L |
| Beginning Cash Position | ₹19,974.00L | ₹9,425.00L | ₹5,602.00L | ₹5,087.00L |
| Issuance Of Capital Stock | ₹448.00L | ₹722.00L | ₹454.00L | ₹227.80L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹83,119.00L | ₹72,016.00L | ₹51,614.00L | ₹43,081.10L | ₹0.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹1,11,068.00L | ₹1,03,562.00L | ₹69,865.00L | ₹54,789.90L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹61,952.00L | ₹35,184.00L | ₹39,205.00L | ₹38,215.80L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹2,29,669.00L | ₹2,14,916.00L | ₹1,60,366.00L | ₹1,30,473.80L | ₹0.00L |
| Pretax Income | ₹63,854.00L | ₹48,887.00L | ₹43,134.00L | ₹40,464.30L | ₹0.00L |
| Tax Provision | -₹897.00L | ₹11,420.00L | ₹3,422.00L | ₹3,048.30L | ₹0.00L |
| Total Revenue | ₹3,11,489.00L | ₹2,87,926.00L | ₹1,99,130.00L | ₹1,66,181.60L | ₹0.00L |
| Cost Of Revenue | ₹81,820.00L | ₹73,010.00L | ₹38,764.00L | ₹35,707.80L | ₹0.00L |
| Total Expenses | ₹2,27,358.00L | ₹2,17,596.00L | ₹1,49,589.00L | ₹1,23,962.50L | ₹0.00L |
| Interest Income | ₹347.00L | ₹506.00L | ₹701.00L | ₹229.90L | ₹0.00L |
| Interest Expense | ₹19,265.00L | ₹23,129.00L | ₹8,480.00L | ₹2,616.80L | ₹0.00L |
| Operating Income | ₹84,131.00L | ₹70,330.00L | ₹49,541.00L | ₹42,219.10L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹1,12,728.00L | ₹1,03,255.00L | ₹69,191.00L | ₹54,282.20L | ₹0.00L |
| Normalized Income | ₹62,948.00L | ₹34,948.72L | ₹38,582.02L | ₹37,746.28L | ₹0.00L |
| Operating Expense | ₹1,45,538.00L | ₹1,44,586.00L | ₹1,10,825.00L | ₹88,254.70L | ₹0.00L |
| Operating Revenue | ₹3,11,489.00L | ₹2,87,926.00L | ₹1,99,130.00L | ₹1,66,181.60L | ₹0.00L |
| Net Interest Income | -₹18,920.00L | -₹22,623.00L | -₹7,779.00L | -₹2,386.90L | ₹0.00L |
| Total Unusual Items | -₹1,660.00L | ₹307.00L | ₹674.00L | ₹507.70L | ₹0.00L |
| Basic Average Shares | ₹1,366.76L | ₹1,360.95L | ₹1,360.14L | ₹1,359.79L | ₹0.00L |
| Diluted Average Shares | ₹1,368.75L | ₹1,362.93L | ₹1,361.68L | ₹1,361.68L | ₹0.00L |
| Total Other Finance Cost | ₹2.00L | ₹0.00L | ₹0.00L | ₹17.70L | ₹7.30L |
| Other Operating Expenses | ₹32,265.00L | ₹30,201.00L | ₹27,006.00L | ₹22,473.70L | ₹0.00L |
| Reconciled Depreciation | ₹27,949.00L | ₹31,546.00L | ₹18,251.00L | ₹11,708.80L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹81,820.00L | ₹73,010.00L | ₹38,764.00L | ₹35,707.80L | ₹0.00L |
| Rent Expense Supplemental | ₹185.00L | ₹294.00L | ₹323.00L | ₹222.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹664.00L | ₹71.72L | ₹51.02L | ₹38.18L | ₹0.00L |
| Interest Income Non Operating | ₹347.00L | ₹506.00L | ₹701.00L | ₹229.90L | ₹0.00L |
| Selling And Marketing Expense | ₹20,576.00L | ₹25,321.00L | ₹18,018.00L | ₹15,827.40L | ₹0.00L |
| Interest Expense Non Operating | ₹19,265.00L | ₹23,129.00L | ₹8,480.00L | ₹2,616.80L | ₹0.00L |
| Net Income Common Stockholders | ₹61,952.00L | ₹35,184.00L | ₹39,205.00L | ₹38,215.80L | ₹0.00L |
| Net Income Continuous Operations | ₹64,751.00L | ₹37,467.00L | ₹39,712.00L | ₹37,416.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹61,952.00L | ₹35,184.00L | ₹39,205.00L | ₹38,215.80L | ₹0.00L |
| General And Administrative Expense | ₹7,631.00L | ₹5,684.00L | ₹7,147.00L | ₹4,717.50L | ₹0.00L |
| Selling General And Administration | ₹28,207.00L | ₹31,005.00L | ₹25,165.00L | ₹20,544.90L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹1,660.00L | ₹307.00L | ₹674.00L | ₹507.70L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹18,920.00L | -₹22,623.00L | -₹7,779.00L | -₹2,386.90L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹64,751.00L | ₹37,467.00L | ₹39,712.00L | ₹37,416.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹61,952.00L | ₹35,184.00L | ₹39,205.00L | ₹38,215.80L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹61,952.00L | ₹35,184.00L | ₹39,205.00L | ₹38,215.80L | ₹0.00L |
Company Performance (FY23–FY26)
₹3.1 K Cr₹2.3 K Cr₹1.6 K Cr₹778.7 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 25/01/2007 | Inderjeet Singh Negi | 01255388 | Whole-time director | View other directorships |
| 27/01/2007 | Amit Indubhushan Bakshi | 01250925 | Managing Director | View other directorships |
| 21/09/2016 | Milind Talegaonkar | *****4138Q | Company Secretary | |
| 28/09/2016 | Sachin Shah | *****1782P | CFO | |
| 30/04/2018 | Prashant Gupta | 08122641 | Director | View other directorships |
| 04/08/2020 | Kaushal Kamlesh Shah | 01229038 | Director | View other directorships |
| 19/12/2020 | Rajeev Dalal | 00222650 | Director | View other directorships |
| 20/12/2020 | Krishnakumar Vaidyanathan | 08976508 | Whole-time director | View other directorships |
| 05/01/2021 | Kalpana Vasantrai Unadkat | 02490816 | Director | View other directorships |
| 25/07/2022 | Vasudevan Sujesh | 08240092 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 10
- Amit Indubhushan BakshiManaging Director
- Krishnakumar VaidyanathanWhole-time director
- Inderjeet Singh NegiWhole-time director
- Vasudevan SujeshDirector
- Kalpana Vasantrai UnadkatDirector
- Rajeev DalalDirector
- Kaushal Kamlesh ShahDirector
- Prashant GuptaDirector
- Sachin ShahCFO
- Milind TalegaonkarCompany Secretary
Subsidiaries 2
- Eris Healthcare Private LimitedDirect
- Eris Oaknet Healthcare Private LimitedDirect
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 20/09/2024 | Form Addendum to AOC-4 CSR-10072024 | - |
| 13/06/2024 | Form MGT-7-13062024_signed | - |
| 11/06/2024 | Form MGT-7-11062024 | - |
| 08/02/2024 | Form AOC-4(XBRL)-08022024_signed | - |
| 06/02/2024 | Form AOC-4(XBRL)-06022024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Eris Healthcare Private Limited | 3358006EY7T6P363CA90 |
| Direct | Eris Oaknet Healthcare Private Limited | 335800XPYFQIKTP8GP11 |
Address
Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380054
Frequently Asked Questions
What is the incorporation date of Eris Lifesciences Limited?
The incorporation date of Eris Lifesciences Limited is 24/01/2007.
What is the authorized share capital and paid-up capital of Eris Lifesciences Limited?
The authorized share capital of Eris Lifesciences Limited is ₹30,00,00,000.00. The paid-up capital is ₹13,61,05,792.00.
Who are the current board members & directors of Eris Lifesciences Limited?
The current board member of Eris Lifesciences Limited are:
- Kalpana Vasantrai Unadkat
- Prashant Gupta
- Amit Indubhushan Bakshi
- Kaushal Kamlesh Shah
- Vasudevan Sujesh
- Inderjeet Singh Negi
- Krishnakumar Vaidyanathan
- Rajeev Dalal
What is the registered address of Eris Lifesciences Limited?
The registered address of Eris Lifesciences Limited is Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Ahmedabad, Gujarat, India, 380054.
What is the Corporate Identification Number of Eris Lifesciences Limited?
The Corporate Identification Number of Eris Lifesciences Limited is L24232GJ2007PLC049867.